- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
UCLA acquires SGI supercomputer
The University of California, Los Angeles, has purchased a Silicon Graphics visualization supercomputer to enhance and expedite efforts by the International Brain Mapping Consortium to create a map of structure and function within the human brain,
The University of California, Los Angeles, has purchased a Silicon Graphics visualization supercomputer to enhance and expedite efforts by the International Brain Mapping Consortium to create a map of structure and function within the human brain, according to Silicon Graphics. UCLA's neuroscientists will use SGI's Onyx2 RealityMonster supercomputer to view and manipulate 3-D brain images.
UCLA scientists have been working with other research centers around the world for five years, compiling data from MRI, PET, CT, and optical intrinsic signal imaging (OIS). Direct anatomical data from cadaveric brains were also included in the database. Onyx2 RealityMonster enables advanced brain modeling and studies of brain development and the aging process, as well as ongoing work to pinpoint specific higher mental functions within the brain, such as memory, language, and planning, according to Mountain View, CA-based SGI.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
